You are here: Industry Insights > Ivermectin

News List

Where can you find the price of Ivermectin API Powder and buy in bulk? PharmaSources
June 04, 2021
Ivermectin is an anthelminthic, a drug that rids the body of parasitic worms, or helminths, either by stunning them or killing them. They exterminate the parasites without causing remarkable damage to the host.
South Africa Breaks Ground In Use of Ivermectin in Covid-19 Treatment Shem Oirere
April 28, 2021
South Africa has taken the lead on the controversial use of ivermectin, distributed under the brand name Mectizan, in the treatment of Covid-19.
Insurance Often Covers Ivermectin for COVID-19, Even Though Drug Doesn't Work drugs.com
January 17, 2022
U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds.
Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMune™ and Ivermectin in Animal Models of COVID-19 Pathology prnewswire
September 23, 2021
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating positive effects when its commercially available nutraceutical, QuadraMune™...
Stop Using Ivermectin Veterinary Drug to Treat COVID-19, FDA Urges drugs
August 24, 2021
Taking a drug meant for horses and cattle to prevent or treat COVID-19 is dangerous and could be fatal, the U.S. Food and Drug Administration warns.
WHO recommends against ivermectin for COVID-19 expresspharma
April 02, 2021
The World Health Organization (WHO) on Wednesday recommended against using generic anti-parasite drug ivermectin in patients with COVID-19 except for clinical trials, because of a lack of data demonstrating its benefits.
EMA advises against ivermectin use for Covid-19 outside clinical trials pharmaceutical-technology
March 24, 2021
The European Medicines Agency (EMA) has advised against the use of Merck’s anti-parasite drug ivermectin for the prevention or treatment of Covid-19 outside randomised clinical trials.
Ivermectin not beneficial to symptom resolution in mild COVID-19 patients europeanpharmaceuticalreview
March 08, 2021
In a trial of over 400 adult patients with mild COVID-19, ivermectin did not significantly improve the time to symptom resolution compared to placebo.
AIIMS find ivermectin prophylaxis reduces infection in Covid-19 patients pharmaceutical-technology
November 06, 2020
A study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha found that two doses of potential drug ivermectin prophylaxis resulted in a 73% reduction in Covid-19 infection.
AIIMS study finds ivermectin prophylaxis reduces infection in Covid-19 patients pharmaceutical-technology
November 06, 2020
A study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha has found that two doses of potential drug ivermectin prophylaxis resulted in a 73% reduction in Covid-19 infection.

Previous page 1 2 Next page